Patient support organization Smáci, z.s. associating patients with spinal muscular atrophy
Authors:
V. Hradilek
Authors‘ workplace:
Fakulta životního prostředí, Česká zemědělská univerzita, Praha
Published in:
Cesk Slov Neurol N 2020; 83/116(Supplementum 2): 45-46
doi:
https://doi.org/10.48095/cccsnn20202S45
Overview
Patient organizations (PO) are an important link in the care of patients with rare diseases. These organizations are often associations of patients and their legal representatives who associate on the basis of the current lack of care for these patients. PO SMÁci, z.s. defends the interests of patients with spinal muscular atrophy (SMA) and their families. In 2017, SMÁci helped to promote the treatment of SMA disease in an accelerated process, using a newly registered drug (Spinraza). Until 2017, no medicinal product was registered for SMA under the EMA. At present, patients in the Czech Republic already have 3 treatments available (Spinraza, Zolgensma and Evrisdy). PO SMÁci are in discussion with the stakeholders of the Czech health care system about new treatments which are currently in the development. PO SMÁci promotes the improvement of care for patients with SMA within three main areas, which include patient support, health policy and research.
Keywords:
spinal muscular atrophy – patient organization – health technology assessment – health policy
Sources
1. Mercuri E, Finkel RS, Muntoni F et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Nauromuscul Disord 2018; 28(2): 103–115. doi: 10.1016/ j.nmd.2017.11.005.
2. Finkel RS, Mercuri E, Meyer OH et al. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord 2018; 28(3): 197–207. doi: 10.1016/ j.nmd.2017.11.004.
3. Strenková J, Voháňka S, Haberlová J et al. REaDY – český registr svalových dystrofií. Cesk Slov Neurol N 2014; 77/ 110(2): 230–234.
4. SMÁci, z. s. – pacientská organizace. [online]. Dostupné z URL: https:/ / smaci.cz/ .
Labels
Paediatric neurology Neurosurgery NeurologyArticle was published in
Czech and Slovak Neurology and Neurosurgery
2020 Issue Supplementum 2
- Hope Awakens with Early Diagnosis of Parkinson's Disease Based on Skin Odor
- Metamizole vs. Tramadol in Postoperative Analgesia
- Memantine in Dementia Therapy – Current Findings and Possible Future Applications
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Memantine Eases Daily Life for Patients and Caregivers
-
All articles in this issue
- Editorial
- Treatment of adults with 5q SMA in the Czech Republic
- The role of a neurologist in multidisciplinary care of patients with spinal muscular atrophy
- Clinical features of spinal muscular atrophy in children
- Clinical manifestations of spinal muscular atrophy in adult patients
- Genetics of spinal muscular atrophy
- Therapy of spinal muscular atrophy
- The functional assessment and tests for children patients with spinal muscular atrophy
- Motor function measures in adult paients with spinal muscular atrophy
- Rehabilitation in spinal muscular atrophy
- Pulmonary management of spinal muscular atrophy
- The role of spine surgery in the care of SMA patients
- Patient support organization Smáci, z.s. associating patients with spinal muscular atrophy
- Diagnostický algoritmus spinální muskulární atrofie
- Czech and Slovak Neurology and Neurosurgery
- Journal archive
- Current issue
- About the journal
Most read in this issue
- Clinical manifestations of spinal muscular atrophy in adult patients
- Genetics of spinal muscular atrophy
- Therapy of spinal muscular atrophy
- Rehabilitation in spinal muscular atrophy